Leverage Technology Platforms (“Big Data”) — SJA has access to over 1,000+ “Active” (seeking to transact) emerging growth companies sourced via online portals, HealthiosXchange (U.S. & Europe) and Capbridge (Asia-Pacific)

Company Breadth — Identify companies by market sector (46), financing stage (seed-to-exit), and stage of development (Pre/Clinical—Marketed)

Notifications (“First Mover Advantage”) — “Follow” companies and receive catalyst updates in real- time meaningful to company evaluation/due diligence


“Rolodex” — SJA and investment banking partner, Healthios, have an extensive network of C-level suite executives at leading biopharma, medical device, medtech, and healthcare services companies

Events — SJA connects companies and strategic buyers via online (webinars) and offline events (one- on-one’s, Healthios conferences-JP Morgan)

Online Data Room — SJA provides valued tools for strategic buyers to efficiently conduct due dilligence on companies of interest via online data rooms